Exemestane is a medication used to treat postmenopausal women with breast cancer. It belongs to a class of drugs called aromatase inhibitors, which work by reducing the production of estrogen in the body. This helps to slow down or stop the growth of hormone-receptor-positive breast cancer cells. Exemestane is taken orally in the form of tablets and is usually prescribed for a specific duration of treatment. Common side effects of Exemestane may include hot flashes, fatigue, and joint pain. Patients should follow their healthcare provider’s instructions and report any persistent or severe side effects.

Letrozole 2.5 mg/ml is a medication available in oral solution form. It contains the active ingredient Letrozole, which belongs to a class of drugs known as aromatase inhibitors. Letrozole is used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women.

T3, also known as Liothyronine, is a synthetic thyroid hormone used primarily for the treatment of hypothyroidism, a condition characterized by an underactive thyroid gland. This medication contains Liothyronine sodium, the synthetic form of the naturally occurring thyroid hormone triiodothyronine (T3). It is available in a liquid formulation with a concentration of 100 micrograms (mcg) per milliliter (mL).

Tamoxifen Citrate is a medication commonly used for the treatment of breast cancer. It works by blocking the effects of estrogen in the breast tissue, which can help prevent the growth and spread of cancer cells. It is also sometimes used to reduce the risk of breast cancer in women who are at high risk for the disease. Tamoxifen Citrate is typically taken in pill form and may have side effects such as hot flashes, headaches, and nausea. It is important for patients to discuss the risks and benefits of this medication with their healthcare provider.